Loading...
Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach
AIMS: Glycopyrronium bromide (NVA237) is a once-daily long-acting muscarinic antagonist recently approved for the treatment of chronic obstructive pulmonary disease. In this study, we used population pharmacokinetic (PK) modelling to provide insights into the impact of the lung PK of glycopyrronium...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845310/ https://ncbi.nlm.nih.gov/pubmed/23506208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12118 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|